• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.56% Nasdaq Down0.79%

    Del Mar Pharmaceuticals Inc. (DMPI)

    -Other OTC
    1.17 Up 0.01(0.86%) 3:55PM EDT
    ProfileGet Profile for:
    Del Mar Pharmaceuticals Inc.
    999 West Broadway
    Suite 720
    Vancouver, BC V5Z 1K5
    Canada - Map
    Phone: 604-629-5989
    Website: http://www.delmarpharma.com

    Index Membership:N/A
    Full Time Employees:4

    Business Summary 

    DelMar Pharmaceuticals, Inc., a clinical stage company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients who have failed to respond to modern therapy. Its product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which is in Phase I/II study to evaluate the safety, tolerability, pharmacokinetics, and anti-cancer activity in patients with glioblastoma multiforme, a form of brain cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company for the manufacture and sale of VAL-083 in China; and collaboration with the University of Texas MD Anderson Cancer Center. DelMar Pharmaceuticals, Inc. was founded in 2009 and is headquartered in Vancouver, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Del Mar Pharmaceuticals Inc.

    Key Executives 
    Mr. Jeffrey A. Bacha B.Sc., M.B.A., 48
    Co-Founder, Chairman, Chief Exec. Officer and Pres
    Dr. Dennis M. Brown B.Sc., M.A., Ph.D., 67
    Co-Founder, Chief Scientific Officer and Director
    Mr. Scott Praill CA, 49
    Chief Financial Officer and Principal Accounting Officer
    Dr. Victor Levin M.D.,
    Dr. James Perry M.D., F.R.C.P.C.,
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders